Want to see AU:DVL full AI Analyst Report?
DVL Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.06
Previous CloseN/A
Volume1.00M
Average Volume (3M)436.08K
Market Cap
AU$28.79M
Enterprise ValueAU$38.99M
Total Cash (Recent Filing)AU$2.12M
Total Debt (Recent Filing)AU$68.25K
Price to Earnings (P/E)―
Beta1.93
Next Earnings
Feb 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,370,937,500
10 Day Avg. Volume120,112
30 Day Avg. Volume436,077
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)9.06
Price to Sales (P/S)39.12
P/FCF Ratio-7.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Digital Health Product PlatformThe combination of wearable hardware and software creates a focused digital-health platform with applications across clinical assessment, rehabilitation, physiotherapy, and occupational health. Objective movement data can support professional decision-making and provides a durable basis for serving multiple healthcare and workplace use cases.
Low Financial LeverageMinimal debt reduces the company’s solvency exposure and interest burden, preserving more financial flexibility than a highly leveraged balance sheet would. This provides a degree of resilience while the business works to improve profitability, although it does not by itself solve the underlying earnings weakness.
Expanded Capital BaseMeaningfully higher equity since 2024 has strengthened the reported capital base and provides a larger buffer against ongoing operating losses. A stronger equity position can support continued investment in the company’s technology and commercial activities, even though returns on that capital remain negative.
Bears Say
Volatile, Declining RevenueThe long-term decline and volatility in revenue indicate that commercial adoption has not yet developed into a consistent growth engine. An isolated rebound does not remove the broader trend, leaving the company with less operating scale and making sustained investment and profitability harder to achieve.
Persistent And Worsening LossesRecurring losses across every year shown, combined with sharply worse 2026 profitability and deeply negative gross profit, point to weak operating leverage and a cost structure that is too high for the current scale. Continued losses can limit reinvestment capacity and prolong the path to self-funded growth.
Ongoing Cash BurnPersistent negative operating and free cash flow means the business is not currently funding itself through operations and may need external funding over time. The significantly larger 2026 operating outflow increases pressure on liquidity and can constrain the pace or scope of future product and commercial investment.
dorsaVi Limited News
DVL FAQ
What was dorsaVi Limited’s price range in the past 12 months?
dorsaVi Limited lowest share price was AU$0.02 and its highest was AU$0.06 in the past 12 months.
What is dorsaVi Limited’s market cap?
dorsaVi Limited’s market cap is AU$28.79M.
When is dorsaVi Limited’s upcoming earnings report date?
dorsaVi Limited’s upcoming earnings report date is Feb 23, 2027 which is in 114 days.
How were dorsaVi Limited’s earnings last quarter?
dorsaVi Limited released its earnings results on Aug 21, 2026. The company reported -AU$0.004 earnings per share for the quarter.
Is dorsaVi Limited overvalued?
According to Wall Street analysts dorsaVi Limited’s price is currently Overvalued.
Does dorsaVi Limited pay dividends?
dorsaVi Limited does not currently pay dividends.
What is dorsaVi Limited’s EPS estimate?
dorsaVi Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does dorsaVi Limited have?
dorsaVi Limited has 1,370,937,500 shares outstanding.
What happened to dorsaVi Limited’s price movement after its last earnings report?
dorsaVi Limited reported an EPS of -AU$0.004 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of dorsaVi Limited?
Currently, no hedge funds are holding shares in AU:DVL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
dorsaVi Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:DVL Sentiment 92%
Sector Average 64%
Sector Average 64%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.25%
12-Months-Change
Fundamentals
Return on Equity
-165.14%
Trailing 12-Months
Asset Growth
47.26%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
dorsaVi Limited
dorsaVi Ltd, an Australian company established in 2008 and based in Oakleigh South, focuses on creating and distributing advanced motion analysis technologies throughout Australia, Europe, and the United States. Its product portfolio includes ViMove+, offering comprehensive solutions for both clinical and athletic applications. For workplace safety, dorsaVi provides ViSafe, a wearable sensor system engineered to track, analyze, and report on workforce movements, highlighting and pinpointing unsafe practices that contribute to occupational injuries. This is complemented by myViSafe technology, which enables organizations and on-site clinicians to identify, reduce, and prevent injury risks in the workplace, fostering positive behavioral changes. Additionally, the company offers ViPerform, a wearable and wireless movement sensor technology that supplies objective data for assessing the likelihood of sports injuries and guiding effective athletic training and recovery programs. dorsaVi also delivers telehealth solutions and professional suites to its clients.
Technical Analysis
Catapult Group International
―
X2M Connect Limited
―
Vection Technologies Ltd.
―
Audeara Ltd.
―
Nanoveu Ltd.
―